Swiss pharmaceutical and diagnostics giant Roche has officially confirmed to Reuters that it is maintaining its planned capital investments in... Read more
Category: Uncategorized
Samsung Electronics invests $175 million to become the largest shareholder in US genetics firm Element Biosciences
South Korean technology giant Samsung Electronics has officially announced a $175 million capital deployment into Element Biosciences, a privately held,... Read more
Gilead’s Trodelvy stumbles in first-line lung cancer trial, opening doors for Merck, AstraZeneca, and Daiichi Sankyo rivals
Gilead Sciences and its partner Merck & Co. have officially announced the discontinuation of their Phase 3 Evoke-03 clinical trial... Read more
WuXi AppTec lands on Pentagon blacklist, facing Biosecure Act restrictions over military links
Chinese CDMO WuXi AppTec has once again entered the crosshairs of the United States government after being added to the... Read more
Drug Administration of Vietnam fines Minh Dan Pharma 90 million VND over marketing authorization violations
The Drug Administration of Vietnam, operating under the Ministry of Health, has officially handed down an administrative sanction decree targeting... Read more
Ministry of Health mandates stricter internet advertising controls and intensified crackdowns on counterfeit food
The Vietnam Food Administration (VFA), operating under the Ministry of Health, has dispatched an official directive to provincial and municipal... Read more
Drug Administration of Vietnam fines Nam Ha Pharma and Minh Dan Pharma over marketing authorization violations
The Drug Administration of Vietnam, operating under the Ministry of Health, has handed down administrative sanction decrees targeting two domestic... Read more
Haleon to invest Rs 2,000 crore to establish first manufacturing facility in India and South Asia
UK-based consumer healthcare giant Haleon, formerly known as GSK Consumer Healthcare, has announced an investment of approximately Rs 2,000 crore... Read more
GSK secures $10.6 billion takeover of Nuvalent to reinforce oncology pipeline with multi-blockbuster lung cancer assets
British drugmaker GSK has entered into a definitive agreement to acquire US-listed lung cancer biotechnology firm Nuvalent for an aggregate... Read more









